Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on ResMed.
RELATED STOCKHEAD STORIES
Health & Biotech
Biocurious: From drug prices to efficiency drives, ASX biotechs await the ‘Trumpcare’ health fallout
Experts
Hot Money Monday: Why these 12 ASX stocks could score big under Trump’s trade threats
Experts
CRITERION: Share valuations look overheated, but it’s a tale of two sectors
Health & Biotech
Health Check: Sleep-maker Resmed recovers from ‘nonsense’ sell-off spurred by rise of fat-busting drugs
News
Closing Bell: WiseTech carries the ASX, Qantas lifts, and AVM soars on silver mine acquisition
Health & Biotech
Scott Power: Which ASX health stocks reaffirm FY25 guidance?
News
ASX Small Caps Lunch Wrap: ASX moves up after Wisetech CEO steps down
Health & Biotech
Scott Power: This sleep devices maker is dreaming big with its 2030 strategy
Health & Biotech
September Health Winners: EZZ and Althea lead upbeat sector sparked by Fed rate cut
News
ASX Small Caps Lunch Wrap: China goes big then goes home, local markets dip despite iron surge
News
ASX Small Caps Lunch Wrap: Markets flat ahead of US rate call. It’s eerily quiet today
Health & Biotech
Wake Up! Don’t get caught sleeping on these three dreamy stocks
Health & Biotech
July Health Winners: Oncosil, Zelira lead as ASX biotechs power through another strong month
Health & Biotech
‘Huge economic potential’ – Moves to make Australia shine as a medical manufacturer
News
Does anyone still remember how to play the ASX IPO game?
News
Closing Bell: ASX smashed as miners go missing
News
